WHO ICTRP trial
A Study of Nivolumab + Chemotherapy or Nivolumab + Ipilimumab Versus…
EUCTR2017-002672-38-ES · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2017-002672-38-ES |
|---|---|
| Public title | A Study of Nivolumab + Chemotherapy or Nivolumab + Ipilimumab Versus Chemotherapy in Patients With EGFR Mutation, T790M Negative NSCLC Who Have Failed 1L EGFR TKI Therapy |
| Scientific title | Open-Label, Randomized Trial of Nivolumab (BMS-936558) plus Pemetrexed/Platinum or Nivolumab plus Ipilimumab (BMS-734016) vs Pemetrexed plus Platinum in Stage IV or Recurrent Non-Small Cell Lung Cancer (NSCLC) Subjects with Epidermal Growth Factor Receptor (EGFR) Mutation, T790M Negative Who Failed… |
| Primary sponsor | Bristol-Myers Squibb International Corporation |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): yes Therapeutic use (Phase IV): no |
| Countries | France;Taiwan;Hong Kong;Spain;Singapore;Japan;China;Korea, Republic of |
| Conditions | Subjects with EGFR mutation, T790M negative NSCLC who failed first line (1L) EGFR TKI therapy MedDRA version: 20.0 Level: PT Classification code 10029515 Term: Non-small cell lung cancer recurrent System Organ Class: 10029104 - Neoplasms… |
| Interventions | Trade Name: Opdivo Product Name: NIVOLUMAB Product Code: BMS-936558 Pharmaceutical Form: Concentrate for solution for infusion INN or Proposed INN: NIVOLUMAB CAS Number: 946414-94-4 Current Sponsor code: BMS-936558-01 Other descriptive… |
| Registration date | Sep 18, 2017 |
| Target size | 465 |
| Secondary IDs | CA209-722;NCT02864251 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: